Richard Kirkeeide
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard Kirkeeide has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Amanda E. Roby
Weatherhead PET Center, McGovern Medical School, University of Texas, Houston
3 shared publications - Danai Kitkungvan
Division of Cardiology, McGovern Medical School, University of Texas, Houston
3 shared publications - Kenneth Lance Gould
From the Weatherhead PET Center for Preventing and Reversing Atherosclerosis, Division of Cardiology, Department of Medicine, McGovern Medical School, University of Texas, and Memorial Hermann Hospital, Houston, TX, USA
3 shared publications - Linh Bui
Division of Cardiology, McGovern Medical School, University of Texas, Houston
3 shared publications - Monica B. Patel
Weatherhead PET Center, Division of Cardiology, McGovern Medical School, University of Texas, Houston
3 shared publications - Nils P. Johnson
Weatherhead PET Center, Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital, Houston, Texas, USA
3 shared publications
Latest Publications
- Open Access
- 16 May 2024
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 38, 101884
Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress
- 16 May 2024
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 38, 101884
Open AccessQuantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress
- Open Access
- 27 August 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (3) , 181-194
Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications
Coronary flow capacity (CFC) is associated with an observed 10-year survival probability for individual patients before and after actual revascularization for comparison to virtual hypothetical ideal complete revascularization. Stress myocardial perfusion (mL/min/g) and coronary flow reserve (CFR) per pixel were quantified in 6979 coronary artery disease (CAD) subjects using Rb-82 positron emission tomography (PET) for CFC maps of artery-specific size-severity abnormalities expressed as percent left ventricle with prospective follow-up to define survival probability per-decade as fraction of 1.0. Severely reduced CFC in 6979 subjects predicted low survival probability that improved by 42% after revascularization compared with no revascularization for comparable severity (P = .0015). For 283 pre-and-post-procedure PET pairs, severely reduced regional CFC-associated survival probability improved heterogeneously after revascularization (P < .001), more so after bypass surgery than percutaneous coronary interventions (P < .001) but normalized in only 5.7%; non-severe baseline CFC or survival probability did not improve compared with severe CFC (P = .00001). Observed CFC-associated survival probability after actual revascularization was lower than virtual ideal hypothetical complete post-revascularization survival probability due to residual CAD or failed revascularization (P < .001) unrelated to gender or microvascular dysfunction. Severely reduced CFC in 2552 post-revascularization subjects associated with low survival probability also improved after repeat revascularization compared with no repeat procedures (P = .025). Severely reduced CFC and associated observed survival probability improved after first and repeat revascularization compared with no revascularization for comparable CFC severity. Non-severe CFC showed no benefit. Discordance between observed actual and virtual hypothetical post-revascularization survival probability revealed residual CAD or failed revascularization. Coronary flow capacity (CFC) and survival prediction after revascularization: physiological basis and clinical implications. CFC maps in one view before (upper row) and after revascularization (lower row) show residual diffuse coronary artery disease (CAD), stenosis, and incomplete or inappropriate revascularization as examples from 283 pre-post-revascularization positron emission tomography (PET) pairs. The 10-year survival probability is determined as a fraction of one for normal CFC (all red) by the proportional distribution of regional size-severity CFC abnormalities. The individual observed survival probabilities for each CFC map before and after actual coronary revascularization are listed below each CFC map. The virtual survival probability predicted for the baseline CFC map after virtual theoretical ideal complete revascularization is listed in the lowest (3rd) row for each case. The plots show the observed survival probability of 6979 PET cases with and without severely reduced CFC with and without non-randomized revascularization followed over 12 years as the database from which individual survival probability is determined by multi-variable CFC components by Cox regression modelling. LAD, left anterior descending coronary artery; LCx, left circumflex artery; RCA, right coronary artery.
- 27 August 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (3) , 181-194
Open AccessCoronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications
Coronary flow capacity (CFC) is associated with an observed 10-year survival probability for individual patients before and after actual revascularization for comparison to virtual hypothetical ideal complete revascularization. Stress myocardial perfusion (mL/min/g) and coronary flow reserve (CFR) per pixel were quantified in 6979 coronary artery disease (CAD) subjects using Rb-82 positron emission tomography (PET) for CFC maps of artery-specific size-severity abnormalities expressed as percent left ventricle with prospective follow-up to define survival probability per-decade as fraction of 1.0. Severely reduced CFC in 6979 subjects predicted low survival probability that improved by 42% after revascularization compared with no revascularization for comparable severity (P = .0015). For 283 pre-and-post-procedure PET pairs, severely reduced regional CFC-associated survival probability improved heterogeneously after revascularization (P < .001), more so after bypass surgery than percutaneous coronary interventions (P < .001) but normalized in only 5.7%; non-severe baseline CFC or survival probability did not improve compared with severe CFC (P = .00001). Observed CFC-associated survival probability after actual revascularization was lower than virtual ideal hypothetical complete post-revascularization survival probability due to residual CAD or failed revascularization (P < .001) unrelated to gender or microvascular dysfunction. Severely reduced CFC in 2552 post-revascularization subjects associated with low survival probability also improved after repeat revascularization compared with no repeat procedures (P = .025). Severely reduced CFC and associated observed survival probability improved after first and repeat revascularization compared with no revascularization for comparable CFC severity. Non-severe CFC showed no benefit. Discordance between observed actual and virtual hypothetical post-revascularization survival probability revealed residual CAD or failed revascularization. Coronary flow capacity (CFC) and survival prediction after revascularization: physiological basis and clinical implications. CFC maps in one view before (upper row) and after revascularization (lower row) show residual diffuse coronary artery disease (CAD), stenosis, and incomplete or inappropriate revascularization as examples from 283 pre-post-revascularization positron emission tomography (PET) pairs. The 10-year survival probability is determined as a fraction of one for normal CFC (all red) by the proportional distribution of regional size-severity CFC abnormalities. The individual observed survival probabilities for each CFC map before and after actual coronary revascularization are listed below each CFC map. The virtual survival probability predicted for the baseline CFC map after virtual theoretical ideal complete revascularization is listed in the lowest (3rd) row for each case. The plots show the observed survival probability of 6979 PET cases with and without severely reduced CFC with and without non-randomized revascularization followed over 12 years as the database from which individual survival probability is determined by multi-variable CFC components by Cox regression modelling. LAD, left anterior descending coronary artery; LCx, left circumflex artery; RCA, right coronary artery.
- 13 January 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (4) , 1528-1539
Does financial hardship associate with abnormal quantitative myocardial perfusion and major adverse cardiovascular event?
- 13 January 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (4) , 1528-1539
Does financial hardship associate with abnormal quantitative myocardial perfusion and major adverse cardiovascular event?